{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:29:37Z","timestamp":1778041777072,"version":"3.51.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","award":["Not available"],"award-info":[{"award-number":["Not available"]}],"id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The mucopolysaccharidoses (MPSs) are lysosomal storage disorders associated with progressive multi-organ and skeletal abnormalities. Clinical manifestations can affect each of the five senses: hearing, vision, smell, taste, and touch.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body of the abstract<\/jats:title>\n                <jats:p>On 24\u201326 May 2018, 46 specialists with expertise in managing symptoms of MPS and experts specialized in evaluating and managing impairments in each one of the five senses gathered in Lisbon, Portugal at the \u201cMPS &amp; the five senses\u201d meeting to discuss how loss of one or multiple senses can affect activities of daily living (ADL) and quality of life (QoL) in MPS patients and best practices in evaluating and managing the loss of senses in these individuals. The meeting confirmed that MPS can affect the senses considerably, but how these impairments affect ADL and overall QoL from a patient\u2019s perspective remains unclear. A better insight may be achieved by prospectively collecting patient-reported outcome (PRO) data internationally in a standardized way, using a standard battery of tools. To identify relevant PRO tools, a systematic literature review and a selection of existing published questionnaires, focused on adults with no intellectual delay, were performed after the meeting. The search strategy identified 33 PRO tools for hearing, 30 for speech, 125 for vision, 49 for touch (including pain and upper limb function), and 15 for smell\/taste. A further selection was made based on several criteria, including applicability\/relevance for MPS, applicability in different countries (languages)\/cultures, availability in English, ease of use, validation, and normative data, resulting in a final set of 11 tools. In addition to these sense-specific PRO tools, a general QoL tool, the EuroQol (EQ)-5D-5\u2009L, was selected to assess overall QoL and reveal coping behaviors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Short conclusion<\/jats:title>\n                <jats:p>MPS can affect each of the five senses, but current knowledge on the impact of sense impairments on QoL\/ADL in MPS patients remains limited. Collection of data in a standardized fashion using sense-specific patient-reported outcome tools and a general QoL tool may fill the current knowledge gap.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-01368-x","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T13:02:21Z","timestamp":1587301341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessing the impact of the five senses on quality of life in mucopolysaccharidoses"],"prefix":"10.1186","volume":"15","author":[{"given":"Roberto","family":"Giugliani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Harmatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuan-Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,19]]},"reference":[{"issue":"Suppl 5","key":"1368_CR1","doi-asserted-by":"publisher","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","volume":"50","author":"J Muenzer","year":"2011","unstructured":"Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011;50(Suppl 5):v4\u2013v12.","journal-title":"Rheumatology (Oxford)"},{"key":"1368_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nchembio.766","volume":"8","author":"R Lawrence","year":"2012","unstructured":"Lawrence R, Brown JR, Al-Mafraji K, Lamanna WC, Beitel JR, Boons GJ, Esko JD, Crawford BE. Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses. Nat Chem Biol. 2012;8:197\u2013204.","journal-title":"Nat Chem Biol"},{"key":"1368_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10545-011-9378-5","volume":"35","author":"A Keilmann","year":"2012","unstructured":"Keilmann A, Nakarat T, Bruce IA, Molter D, Malm G, Investigators HOS. Hearing loss in patients with mucopolysaccharidosis II: data from HOS - the hunter outcome survey. J Inherit Metab Dis. 2012;35:343\u201353.","journal-title":"J Inherit Metab Dis"},{"key":"1368_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13052-018-0559-9","volume":"44","author":"A Del Longo","year":"2018","unstructured":"Del Longo A, Piozzi E, Schweizer F. Ocular features in mucopolysaccharidosis: diagnosis and treatment. Ital J Pediatr. 2018;44:125.","journal-title":"Ital J Pediatr"},{"key":"1368_CR5","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.ijporl.2014.03.021","volume":"78","author":"B G\u00f6n\u00fcldas","year":"2014","unstructured":"G\u00f6n\u00fcldas B, Yilmaz T, Sivri HS, G\u00fc\u00e7er KS, Kilin\u00e7 K, Genc GA, Kili\u00e7 M, Co\u00e7kun T. Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway. Int J Pediatr Otorhinolaryngol. 2014;78:944\u20139.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1368_CR6","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/dmcn.13545","volume":"59","author":"D Viskochil","year":"2017","unstructured":"Viskochil D, Muenzer J, Guffon N, Garin C, Munoz-Rojas MV, Moy KA, Hutchinson DT. Carpal tunnel syndrome in mucopolysaccharidosis I: a registry-based cohort study. Dev Med Child Neurol. 2017;59:1269\u201375.","journal-title":"Dev Med Child Neurol"},{"key":"1368_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/8904_2012_179","volume":"9","author":"R Aslam","year":"2013","unstructured":"Aslam R, van Bommel AC, Hendriksz CJ, Jester A. Subjective and objective assessment of hand function in mucopolysaccharidosis IVa patients. JIMD Rep. 2013;9:59\u201365.","journal-title":"JIMD Rep"},{"key":"1368_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13023-016-0503-2","volume":"11","author":"CJ Hendriksz","year":"2016","unstructured":"Hendriksz CJ, Berger KI, Lampe C, Kircher SG, Orchard PJ, Southall R, Long S, Sande S, Gold JI. Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issues. Orphanet J Rare Dis. 2016;11:119.","journal-title":"Orphanet J Rare Dis"},{"key":"1368_CR9","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.6061\/clinics\/2018\/e523","volume":"73","author":"M Silveira","year":"2018","unstructured":"Silveira M, Buriti AKL, Martins AM, Gil D, Azevedo MF. Audiometric evaluation in individuals with mucopolysaccharidosis. Clinics (Sao Paulo). 2018;73:e523.","journal-title":"Clinics (Sao Paulo)"},{"key":"1368_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000113511","volume":"13","author":"YS Cho","year":"2008","unstructured":"Cho YS, Kim JH, Kim TW, Chung SC, Chang SA, Jin DK. Otologic manifestations of hunter syndrome and their relationship with speech development. Audiol Neurootol. 2008;13:206\u201312.","journal-title":"Audiol Neurootol"},{"key":"1368_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3109\/14015439.2013.776630","volume":"39","author":"T Nakarat","year":"2014","unstructured":"Nakarat T, L\u00e4\u00dfig AK, Lampe C, Keilmann A. Alterations in speech and voice in patients with mucopolysaccharidoses. Logoped Phoniatr Vocol. 2014;39:30\u20137.","journal-title":"Logoped Phoniatr Vocol"},{"key":"1368_CR12","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1111\/jgs.13649","volume":"63","author":"H Amieva","year":"2015","unstructured":"Amieva H, Ouvrard C, Giulioli C, Meillon C, Rullier L, Dartigues JF. Self-reported hearing loss, hearing aids, and cognitive decline in elderly adults: a 25-year study. J Am Geriatr Soc. 2015;63:2099\u2013104.","journal-title":"J Am Geriatr Soc"},{"key":"1368_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0194599816640485","volume":"155","author":"L Roland","year":"2016","unstructured":"Roland L, Fischer C, Tran K, Rachakonda T, Kallogjeri D, Lieu JE. Quality of life in children with hearing impairment: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2016;155:208\u201319.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1368_CR14","first-page":"2S17","volume":"42 Suppl 2","author":"S Arlinger","year":"2003","unstructured":"Arlinger S. Negative consequences of uncorrected hearing loss-a review. Int J Audiol. 2003;42 Suppl 2:2S17\u201320.","journal-title":"Int J Audiol"},{"key":"1368_CR15","doi-asserted-by":"crossref","unstructured":"Manchaiah V, Granberg S, Grover V, Saunders GH, Ann HD. Content validity and readability of patient-reported questionnaire instruments of hearing disability. Int J Audiol. 2019;58:565\u201375.","DOI":"10.1080\/14992027.2019.1602738"},{"key":"1368_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijporl.2009.09.042","volume":"74","author":"SM Wold","year":"2010","unstructured":"Wold SM, Derkay CS, Darrow DH, Proud V. Role of the pediatric otolaryngologist in diagnosis and management of children with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol. 2010;74:27\u201331.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1368_CR17","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.ijporl.2013.05.003","volume":"77","author":"H Saeed","year":"2013","unstructured":"Saeed H, Nichani J, Melling C, Raine CH, Khan I, Martin JM, Bullough R, Green KM, Jones SA, Bruce IA. Feasibility of cochlear implantation in Mucopolysaccharidosis. Int J Pediatr Otorhinolaryngol. 2013;77:1255\u20138.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1368_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1442-9071.2010.02364.x","volume":"38","author":"JL Ashworth","year":"2010","unstructured":"Ashworth JL, Kruse FE, Bachmann B, Tormene AP, Suppiej A, Parini R, Guffon N. Ocular manifestations in the mucopolysaccharidoses - a review. Clin Experiment Ophthalmol. 2010;38:12\u201322.","journal-title":"Clin Experiment Ophthalmol"},{"key":"1368_CR19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1100\/tsw.2003.88","volume":"3","author":"KL Bergwerk","year":"2003","unstructured":"Bergwerk KL, Rabinowitz YS, Falk RE. Quality of life related to visual function in three young adults with mucopolysaccharidoses. ScientificWorldJournal. 2003;3:922\u20139.","journal-title":"ScientificWorldJournal."},{"key":"1368_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/bjophthalmol-2015-307619","volume":"100","author":"P Vashist","year":"2016","unstructured":"Vashist P, Gupta N, Tandon R, Gupta SK, Dwivedi S, Mani K. Population-based assessment of vision-related quality of life in corneal disease: results from the CORE study. Br J Ophthalmol. 2016;100:588\u201393.","journal-title":"Br J Ophthalmol"},{"key":"1368_CR21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/jamaophthalmol.2016.2394","volume":"134","author":"EK Fenwick","year":"2016","unstructured":"Fenwick EK, Ong PG, Man RE, Cheng CY, Sabanayagam C, Wong TY, Lamoureux EL. Association of vision impairment and major eye diseases with mobility and independence in a Chinese population. JAMA Ophthalmol. 2016;134:1087\u201393.","journal-title":"JAMA Ophthalmol"},{"key":"1368_CR22","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/OPX.0000000000000001","volume":"90","author":"J Khadka","year":"2013","unstructured":"Khadka J, McAlinden C, Pesudovs K. Quality assessment of ophthalmic questionnaires: review and recommendations. Optom Vis Sci. 2013;90:720\u201344.","journal-title":"Optom Vis Sci"},{"key":"1368_CR23","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/bjophthalmol-2016-308807","volume":"101","author":"KL Ohden","year":"2017","unstructured":"Ohden KL, Pitz S, Ashworth J, Magalh\u00e4es A, Marinho DR, Lindahl P, Te\u00e4r Fahnehjelm K, Summers CG. Outcomes of keratoplasty in the mucopolysaccharidoses: an international perspective. Br J Ophthalmol. 2017;101:909\u201312.","journal-title":"Br J Ophthalmol"},{"key":"1368_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/8904_2015_513","volume":"29","author":"DRR Pereira","year":"2016","unstructured":"Pereira DRR, Schweiger C, de Souza CF, Fagondes S, Manica D, Giugliani R, Kuhl G, Marostica PJC. Correlation between flexible fiberoptic laryngoscopic and polysomnographic findings in patients with mucopolysaccharidosis type VI. JIMD Rep. 2016;29:53\u20138.","journal-title":"JIMD Rep"},{"key":"1368_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.24953\/turkjped.2018.04.007","volume":"60","author":"E Ballikaya","year":"2018","unstructured":"Ballikaya E, Eymirli PS, Yildiz Y, Avcu N, Sivri HS, Uzamis-Tekcicek M. Oral health status in patients with mucopolysaccharidoses. Turk J Pediatr. 2018;60:400\u20136.","journal-title":"Turk J Pediatr"},{"key":"1368_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00784-017-2100-8","volume":"22","author":"RQ de Almeida-Barros","year":"2018","unstructured":"de Almeida-Barros RQ, de Medeiros PFV, de Almeida Azevedo MQ, de Oliveira Lira Ortega A, Yamamoto ATA, Dornelas SKL, Bento PM. Evaluation of oral manifestations of patients with mucopolysaccharidosis IV and VI: clinical and imaging study. Clin Oral Investig. 2018;22:201\u20138.","journal-title":"Clin Oral Investig"},{"key":"1368_CR27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00405-011-1522-1","volume":"268","author":"A Tsikoudas","year":"2011","unstructured":"Tsikoudas A, Barnes ML, White P. The impact of tracheostomy on the nose. Eur Arch Otorhinolaryngol. 2011;268:1005\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1368_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/chemse\/bjx025","volume":"42","author":"S Boesveldt","year":"2017","unstructured":"Boesveldt S, Postma EM, Boak D, Welge-Luessen A, Sch\u00f6pf V, Mainland JD, Martens J, Ngai J, Duffy VB. Anosmia-A Clinical Review. Chem Senses. 2017;42:513\u201323.","journal-title":"Chem Senses"},{"key":"1368_CR29","doi-asserted-by":"publisher","first-page":"624","DOI":"10.4140\/TCP.n.2016.624","volume":"31","author":"GF Ruggiero","year":"2016","unstructured":"Ruggiero GF, Wick JY. Olfaction: new understandings, diagnostic applications. Consult Pharm. 2016;31:624\u201332.","journal-title":"Consult Pharm"},{"key":"1368_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijporl.2018.04.028","volume":"111","author":"R Harrison","year":"2018","unstructured":"Harrison R, Schaefer S, Warner L, Mercer J, Jones S, Bruce I. Transnasal adenoidectomy in mucopolysaccharidosis. Int J Pediatr Otorhinolaryngol. 2018;111:149\u201352.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1368_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11882-019-0845-7","volume":"19","author":"Z Chandy","year":"2019","unstructured":"Chandy Z, Ference E, Lee JT. Clinical guidelines on chronic rhinosinusitis in children. Curr Allergy Asthma Rep. 2019;19:14.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1368_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1939-4551-7-25","volume":"7","author":"C Bachert","year":"2014","unstructured":"Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, Jirapongsananuruk O, Kern R, Meltzer EO, Mullol J, Naclerio R, Pilan R, Rhee CS, Suzaki H, Voegels R, Blaiss M. ICON: chronic rhinosinusitis. World Allergy Organ J. 2014;7:25.","journal-title":"World Allergy Organ J"},{"key":"1368_CR33","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1152\/jappl.1999.86.4.1202","volume":"86","author":"AM Sanico","year":"1999","unstructured":"Sanico AM, Philip G, Lai GK, Togias A. Hyperosmolar saline induces reflex nasal secretions, evincing neural hyperresponsiveness in allergic rhinitis. J Appl Physiol (1985). 1999;86:1202\u201310.","journal-title":"J Appl Physiol (1985)"},{"key":"1368_CR34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/BPO.0000000000000168","volume":"34","author":"A O'Brien","year":"2014","unstructured":"O'Brien A, Bompadre V, Hale S, White KK. Musculoskeletal function in patients with mucopolysaccharidosis using the pediatric outcomes data collection instrument. J Pediatr Orthop. 2014;34:650\u20134.","journal-title":"J Pediatr Orthop"},{"key":"1368_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3233\/PRM-2010-0102","volume":"3","author":"KK White","year":"2010","unstructured":"White KK, Harmatz P. Orthopedic management of mucopolysaccharide disease. J Pediatr Rehabil Med. 2010;3:47\u201356.","journal-title":"J Pediatr Rehabil Med"},{"key":"1368_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archneur.1974.00490420084010","volume":"31","author":"G Karpati","year":"1974","unstructured":"Karpati G, Carpenter S, Eisen AA, Wolfe LS, Feindel W. Multiple peripheral nerve entrapments. An unusual phenotypical variant of the hunter syndrome (mucopolysaccharidosis II) in a family. Arch Neurol. 1974;31:418\u201322.","journal-title":"Arch Neurol"},{"key":"1368_CR37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1590\/S0021-75572008000200007","volume":"84","author":"A Cardoso-Santos","year":"2008","unstructured":"Cardoso-Santos A, Azevedo ACMM, Fagondes S, Burin MG, Giugliani R, Schwartz IVD. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): assessment of joint mobility and grip and pinch strength. J Pediatr. 2008;84:130\u20135.","journal-title":"J Pediatr"},{"key":"1368_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11832-014-0601-4","volume":"8","author":"KK White","year":"2014","unstructured":"White KK, Jester A, Bache CE, Harmatz PR, Shediac R, Thacker MM, Mackenzie WG. Orthopedic management of the extremities in patients with Morquio a syndrome. J Child Orthop. 2014;8:295\u2013304.","journal-title":"J Child Orthop"},{"key":"1368_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/PRM-2010-0103","volume":"3","author":"K White","year":"2010","unstructured":"White K, Kim T, Neufeld JA. Clinical assessment and treatment of carpal tunnel syndrome in the mucopolysaccharidoses. J Pediatr Rehabil Med. 2010;3:57\u201362.","journal-title":"J Pediatr Rehabil Med"},{"key":"1368_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ymgme.2012.07.018","volume":"107","author":"GA Solanki","year":"2012","unstructured":"Solanki GA, Alden TD, Burton BK, Giugliani R, Horovitz DDG, Jones SA, Lampe C, Martin KW, Ryan ME, Schaefer MK, Siddiqui A, White KK, Harmatz P. A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI. Mol Genet Metab. 2012;107:15\u201324.","journal-title":"Mol Genet Metab"},{"key":"1368_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10545-013-9586-2","volume":"36","author":"GA Solanki","year":"2013","unstructured":"Solanki GA, Martin KW, Theroux MC, Lampe C, White KK, Shediac R, Lampe CG, Beck M, Mackenzie WG, Hendriksz CJ, Harmatz PR. Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio a syndrome): presentation, diagnosis and management. J Inherit Metab Dis. 2013;36:339\u201355.","journal-title":"J Inherit Metab Dis"},{"key":"1368_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/ajmg.a.38014","volume":"173","author":"PR Harmatz","year":"2016","unstructured":"Harmatz PR, Mengel E, Geberhiwot T, Muschol N, Hendriksz CJ, Burton BK, Jameson E, Berger KI, Jester A, Treadwell M, Sisic Z, Decker C. Impact of elosulfase alfa in patients with morquio a syndrome who have limited ambulation: an open-label, phase 2 study. Am J Med Genet A. 2016;173:375\u201383.","journal-title":"Am J Med Genet A"},{"key":"1368_CR43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0363-5023(99)70014-6","volume":"24","author":"I Atroshi","year":"1999","unstructured":"Atroshi I, Gummesson C, Johnsson R, Sprinchorn A. Symptoms, disability, and quality of life in patients with carpal tunnel syndrome. J Hand Surg Am. 1999;24:398\u2013404.","journal-title":"J Hand Surg Am"},{"key":"1368_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2340\/16501977-0934","volume":"44","author":"RI Cederlund","year":"2012","unstructured":"Cederlund RI, Dahlin LB, Thomsen NO. Activity limitations before and after surgical carpal tunnel release among patients with and without diabetes. J Rehabil Med. 2012;44:261\u20137.","journal-title":"J Rehabil Med"},{"key":"1368_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1302\/1863-2548.11.170042","volume":"11","author":"N Williams","year":"2017","unstructured":"Williams N, Challoumas D, Eastwood DM. Does orthopaedic surgery improve quality of life and function in patients with mucopolysaccharidoses? J Child Orthop. 2017;11:289\u201397.","journal-title":"J Child Orthop"},{"key":"1368_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ajmg.a.36833","volume":"167A","author":"CJ Hendriksz","year":"2015","unstructured":"Hendriksz CJ, Berger KI, Giugliani R, Harmatz P, Kampmann C, Mackenzie WG, Raiman J, Villarreal MS, Savarirayan R. International guidelines for the management and treatment of Morquio a syndrome. Am J Med Genet A. 2015;167A:11\u201325.","journal-title":"Am J Med Genet A"},{"key":"1368_CR47","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/dmcn.13127","volume":"58","author":"T B\u00e4umer","year":"2016","unstructured":"B\u00e4umer T, B\u00fchring N, Schelle T, M\u00fcnchau A, Muschol N. Nerve ultrasound in clinical management of carpal tunnel syndrome in mucopolysaccharidosis. Dev Med Child Neurol. 2016;58:1172\u20139.","journal-title":"Dev Med Child Neurol"},{"key":"1368_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/1753193414523356","volume":"40","author":"R Aslam","year":"2015","unstructured":"Aslam R, Hendriksz CJ, Jester A. Objective results of median nerve decompression and tenosynovectomy for carpal tunnel syndrome in patients with mucopolysaccharidoses types I and II. J Hand Surg Eur Vol. 2015;40:216\u20138.","journal-title":"J Hand Surg Eur Vol"},{"key":"1368_CR49","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0193945915615869","volume":"38","author":"R Knoerl","year":"2016","unstructured":"Knoerl R, Lavoie Smith EM, Weisberg J. Chronic pain and cognitive behavioral therapy: an integrative review. West J Nurs Res. 2016;38:596\u2013628.","journal-title":"West J Nurs Res"},{"key":"1368_CR50","volume":"4","author":"LJ Geneen","year":"2017","unstructured":"Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH. Physical activity and exercise for chronic pain in adults: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;4:CD011279.","journal-title":"Cochrane Database Syst Rev"},{"key":"1368_CR51","doi-asserted-by":"publisher","first-page":"S295","DOI":"10.1016\/j.pmrj.2015.09.006","volume":"7","author":"BW Landry","year":"2015","unstructured":"Landry BW, Fischer PR, Driscoll SW, Koch KM, Harbeck-Weber C, Mack KJ, Wilder RT, Bauer BA, Brandenburg JE. Managing chronic pain in children and adolescents: a clinical review. PM R. 2015;7:S295\u2013315.","journal-title":"PM R"},{"key":"1368_CR52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.heares.2014.01.010","volume":"310","author":"AJ Kolarik","year":"2014","unstructured":"Kolarik AJ, Cirstea S, Pardhan S, Moore BC. A summary of research investigating echolocation abilities of blind and sighted humans. Hear Res. 2014;310:60\u20138.","journal-title":"Hear Res"},{"key":"1368_CR53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00221-016-4808-0","volume":"235","author":"C Papagno","year":"2017","unstructured":"Papagno C, Minniti G, Mattavelli GC, Mantovan L, Cecchetto C. Tactile short-term memory in sensory-deprived individuals. Exp Brain Res. 2017;235:471\u201380.","journal-title":"Exp Brain Res"},{"key":"1368_CR54","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727\u201336.","journal-title":"Qual Life Res"},{"key":"1368_CR55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1172-9-32","volume":"9","author":"CJ Hendriksz","year":"2014","unstructured":"Hendriksz CJ, Lavery C, Coker M, Ucar SK, Jain M, Bell L, Lampe C. Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey. Orphanet J Rare Dis. 2014;9:32.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 1","key":"1368_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10198-016-0787-0","volume":"17","author":"M P\u00e9ntek","year":"2016","unstructured":"P\u00e9ntek M, Gul\u00e1csi L, Brodszky V, Baji P, Boncz I, Pog\u00e1ny G, L\u00f3pez-Bastida J, Linertov\u00e1 R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Iskrov G, Schieppati A, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G, Network B-RR. Social\/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe. Eur J Health Econ. 2016;17(Suppl 1):89\u201398.","journal-title":"Eur J Health Econ"},{"key":"1368_CR57","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgmr.2018.03.009","volume":"15","author":"G Pintos-Morell","year":"2018","unstructured":"Pintos-Morell G, Blasco-Alonso J, Couce ML, Gutierrez-Solana LG, Guillen-Navarro E, O'Callaghan M, Del Toro M. Elosulfase alfa for mucopolysaccharidosis type IVA: real-world experience in 7 patients from the Spanish morquio-a early access program. Mol Genet Metab Rep. 2018;15:116\u201320.","journal-title":"Mol Genet Metab Rep"},{"key":"1368_CR58","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3766\/jaaa.16.9.2","volume":"16","author":"GH Saunders","year":"2005","unstructured":"Saunders GH, Cienkowski KM, Forsline A, Fausti S. Normative data for the attitudes towards loss of hearing questionnaire. J Am Acad Audiol. 2005;16:637\u201352.","journal-title":"J Am Acad Audiol"},{"key":"1368_CR59","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/AUD.0b013e3181a61efe","volume":"30","author":"RS Tyler","year":"2009","unstructured":"Tyler RS, Perreau AE, Ji H. The validation of the spatial hearing questionnaire. Ear Hear. 2009;30:466\u201374.","journal-title":"Ear Hear"},{"key":"1368_CR60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1044\/2014_AJA-13-0049","volume":"23","author":"AE Perreau","year":"2014","unstructured":"Perreau AE, Spejcher B, Ou H, Tyler R. The spatial hearing questionnaire: data from individuals with normal hearing. Am J Audiol. 2014;23:173\u201381.","journal-title":"Am J Audiol"},{"key":"1368_CR61","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/hed.20795","volume":"30","author":"RN Rinkel","year":"2008","unstructured":"Rinkel RN, Verdonck-de Leeuw IM, van Reij EJ, Aaronson NK, Leemans CR. Speech handicap index in patients with oral and pharyngeal cancer: better understanding of patients' complaints. Head Neck. 2008;30:868\u201374.","journal-title":"Head Neck"},{"key":"1368_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1044\/2016_JSLHR-S-16-0022","volume":"60","author":"DO Francis","year":"2017","unstructured":"Francis DO, Daniero JJ, Hovis KL, Sathe N, Jacobson B, Penson DF, Feurer ID, McPheeters ML. Voice-related patient-reported outcome measures: a systematic review of instrument development and validation. J Speech Lang Hear Res. 2017;60:62\u201388.","journal-title":"J Speech Lang Hear Res"},{"key":"1368_CR63","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jvoice.2011.04.006","volume":"26","author":"RE Arffa","year":"2012","unstructured":"Arffa RE, Krishna P, Gartner-Schmidt J, Rosen CA. Normative values for the voice handicap index-10. J Voice. 2012;26:462\u20135.","journal-title":"J Voice"},{"key":"1368_CR64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0194-5998(99)70399-2","volume":"120","author":"RE Gliklich","year":"1999","unstructured":"Gliklich RE, Glovsky RM, Montgomery WW. Validation of a voice outcome survey for unilateral vocal cord paralysis. Otolaryngol Head Neck Surg. 1999;120:153\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1368_CR65","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jcrs.2010.01.029","volume":"36","author":"VK Gothwal","year":"2010","unstructured":"Gothwal VK, Wright TA, Lamoureux EL, Pesudovs K. Measuring outcomes of cataract surgery using the visual function index-14. J Cataract Refract Surg. 2010;36:1181\u20138.","journal-title":"J Cataract Refract Surg"},{"key":"1368_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-1-20","volume":"1","author":"B Bruce","year":"2003","unstructured":"Bruce B, Fries JF. The Stanford health assessment questionnaire: dimensions and practical applications. Health Qual Life Outcomes. 2003;1:20.","journal-title":"Health Qual Life Outcomes"},{"key":"1368_CR67","first-page":"1038","volume":"87","author":"DE Beaton","year":"2005","unstructured":"Beaton DE, Wright JG, Katz JN, Upper Extremity Collaborative Group. Development of the QuickDASH: comparison of three item-reduction approaches. J Bone Joint Surg Am. 2005;87:1038\u201346.","journal-title":"J Bone Joint Surg Am"},{"key":"1368_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/1753193413481302","volume":"39E","author":"T Aasheim","year":"2014","unstructured":"Aasheim T, Finsen V. The DASH and the QuickDASH instruments. Normative values in the general population in Norway. J Hand Surg Eur Vol. 2014;39E:140\u20134.","journal-title":"J Hand Surg Eur Vol"},{"key":"1368_CR69","volume-title":"The brief pain inventory user guide","author":"CS Cleeland","year":"2009","unstructured":"Cleeland CS. The brief pain inventory user guide. 2009. Available from https:\/\/www.mdanderson.org\/documents\/Departments-and-Divisions\/Symptom-Research\/BPI_UserGuide.pdf. Last accessed in March 2020."},{"key":"1368_CR70","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0304-3959(85)90004-1","volume":"23","author":"RD Kerns","year":"1985","unstructured":"Kerns RD, Turk DC, Rudy TE. The west haven-Yale multidimensional pain inventory (WHYMPI). Pain. 1985;23:345\u201356.","journal-title":"Pain."},{"key":"1368_CR71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1288\/00005537-199504000-00010","volume":"105","author":"RE Gliklich","year":"1995","unstructured":"Gliklich RE, Metson R. Techniques for outcomes research in chronic sinusitis. Laryngoscope. 1995;105:387\u201390.","journal-title":"Laryngoscope."},{"key":"1368_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6815-6-9","volume":"6","author":"K Stavem","year":"2006","unstructured":"Stavem K, R\u00f8ssberg E, Larsson PG. Reliability, validity and responsiveness of a Norwegian version of the chronic sinusitis survey. BMC Ear Nose Throat Disord. 2006;6:9.","journal-title":"BMC Ear Nose Throat Disord"},{"key":"1368_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0194-5998(97)70199-2","volume":"117","author":"RE Gliklich","year":"1997","unstructured":"Gliklich RE, Metson R. Effect of sinus surgery on quality of life. Otolaryngol Head Neck Surg. 1997;117:12\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1368_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-7596-1","volume-title":"Self-Reported Population Health: An International Perspective based on EQ-5D","author":"A Szende","year":"2014","unstructured":"Szende A, Janssen B, Cabases J. Self-Reported Population Health: An International Perspective based on EQ-5D. Dordrecht: Springer; 2014. Available from http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500356\/. Last accessed in March 2020."},{"key":"1368_CR75","first-page":"8","volume":"123","author":"CJ Hendriksz","year":"2018","unstructured":"Hendriksz CJ, Parini R, AlSayed M, Raiman J, Giugliani R, Mitchell J, Burton BK, Guelbert N, Stewart FJ, Hughes DA, Matousek R, Hawley SM, Decker C, Harmatz PR. Impact of long-term elosulfase alfa on activities of daily living in patients with Morquio a syndrome in an open-label, multi-center, phase 3 extension study. Mol Genet Metab. 2018;123:8.","journal-title":"Mol Genet Metab"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01368-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01368-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01368-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T23:25:49Z","timestamp":1618788349000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01368-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,19]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01368-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,19]]},"assertion":[{"value":"19 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The content of this manuscript is based on discussions during a meeting that was coordinated and funded by BioMarin Pharmaceutical Inc. BioMarin also provided a review of the manuscript. RG, PH, S-PL and MS received funding from BioMarin Pharmaceutical Inc. to participate in this meeting. In addition, RG received speaker honoraria, advisory board and consultancy fees, investigator fees, research grants or travel grants to participate in scientific meetings from Amicus, Actelion, BioMarin, GC Pharma, Inventiva, JCR, Lysogene, PTC, RegenxBio, Sangamo, Sanofi, Sobi, Takeda, and Ultragenyx. MS reports board membership and grants and payments (e.g. for lectures, speakerships, honoraria, travel\/accommodation) from Shire, Genzyme, Chiesi, Ultragenix, and BioMarin. PH has been a consultant for BioMarin, Shire, Genzyme, Chiesi, Inventiva, Paradigm, Ultragenyx, SOBI, JCR, Denali, Orphazyme, RegenXbio, and Sangamo, he received grants from BioMarin, payments (lectures, speakerships, honoraria) from BioMarin, Chiesi, Ultragenyx, and Orphazyme and travel, accommodations, and\/or payments for meeting expenses from BioMarin, Shire, Genzyme, Chiesi, Inventiva, Ultragenyx, SOBI, and RegenXbio.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}